POINT Biopharma Global

-$0.04 (-0.50%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PNT and other ETFs, options, and stocks.

About PNT

POINT Biopharma Global, Inc. engages in the development and commercialization of rediopharmaceuticals for the treatment of cancer Its product candidates includes PNT2002 and PNT2003 for the treatment of prostate cancer and neuroendocrine tumors. The company was founded by Joe McCann on April 15, 2020 and is headquartered in Indianapolis, IN.

CEO
Joe McCann
Employees
31
Headquarters
Indianapolis, Indiana
Founded
2020

PNT Key Statistics

Market Cap
717.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
97.09K
High Today
$8.07
Low Today
$7.88
Open Price
$7.97
Volume
219.90K
52 Week High
$11.72
52 Week Low
$6.64

PNT Earnings

-$0.15
-$0.10
-$0.05
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure